Allied Market Research
Loading...
0
New
New
2022
Nerve Repair And Regeneration Market

Nerve Repair and Regeneration Market by Product (Biomaterials, Neuromodulation Surgery Devices), by Surgery (Direct Neuropathy, Nerve Grafting, Stem Cell Therapy, Neuromodulation Surgery): Global Opportunity Analysis and Industry Forecast, 2020-2030

A00209
Pages: 189
May 2022 | 14600 Views
   
Author(s) : Vikita Thakur, Vidhya Wable , Onkar Sumant
Tables: 116
Charts: 55
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Nerve Repair And Regeneration Market

Request Now !

 

Nerve Repair And Regeneration Market Research, 2030

The global Nerve Repair and Regeneration Market Size was valued at $6.6 billion in 2020 and is projected to reach $12.3 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030. Nerve repair, also known as neuroregeneration, is defined as the repair or regrowth of nervous tissues, and cells through the generation of new neurons, axons, synapses, and myelin.

Nerve repair and regeneration offers products such as neurostimulation, neuromodulator, and biomaterial devices. These devices are used to treat traumatic or neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy. The brain, spinal cord, and peripheral nerves are fragile in nature & easily damaged, and hence can interfere with the brain's ability to communicate with muscles and organs. Nerve repair and regeneration products repair these damages.

The outbreak of COVID-19 negatively impacted the nerve repair and regeneration market, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals across the globe. As many hospitals and clinics remain closed due to lockdown, the demand for nerve repair and regeneration procedures is declined.

Nerve Repair and Regeneration Market, Nerve Repair Market, Nerve Regeneration Market, Nerve Repair and Regeneration Market Size, Nerve Repair and Regeneration Market Share, Nerve Repair and Regeneration Market Analysis, Nerve Repair and Regeneration Market Growth, Nerve Repair and Regeneration Market Opportunity, Nerve Repair and Regeneration Market Trends, Nerve Repair and Regeneration Market Forecast

The key factors that drives nerve repair and regeneration market growth are an increase in the prevalence of neurological & epidemic disorders. According to the journal The Lancet Global Health published in July 2021, it was reported that around 50 million people suffer from epilepsy, globally. As per the same source, it was also reported that around 10-12 million people are diagnosed with epilepsy, in India. An increase in the geriatric population boosts the need for nerve repair and regeneration therapy and drives the growth of the market. According to World Population Ageing, it was observed that approximately 727 million people are aged 65 years or above. In addition, the increase in the number of product launches of innovative products for nerve repair & regeneration drives the market. For instance, in March 2020, Abbott, a pharmaceutical company, announced the launch of a neurosphere virtual clinic, which is the first-of-its-kind remote neuromodulation patient-care technology in the U.S.

The nerve repair and regeneration market opportunity are increased as in developing countries; the expenditure on healthcare is on a continuous rise. The surge in awareness for the use of nerve repair and regeneration devices to manage conditions, such as Alzheimer's disease, Parkinson's disease, and other neurological disorders globally, is expected to promote market growth. Furthermore, a rise in awareness among people about clinical treatments such as immune response & neuroregeneration, spinal cord repair, peripheral nerve regeneration &repair, and nerve cell regrowth is anticipated to expand the nerve repair and regeneration market.

High cost associated with the devices such as neurostimulator devices, the procedure, and dearth of skilled professionals for the utilization of devices is expected to restrict the Nerve Regeneration Market growth during the forecast period.

The nerve repair and regeneration market is segmented on the basis of surgery, product, and region. By surgery, the market is classified into direct neuropathy, nerve grafting, stem cell therapy, and neuromodulation surgery. The direct neuropathy segment is further sub-categorized into epineural repair and perineural repair, and group fascicular repair. The nerve grafting is further sub-categorized into autografts, allografts, and xenografts. The neuromodulation surgery is further sub-categorized into external neuromodulation surgery and internal neuromodulation surgery. By product, the Nerve Repair and Regeneration Industry is divided into biomaterials and neuromodulation surgery devices. The biomaterials segment is further sub-categorized into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neuromodulation surgery devices segment is further sub-categorized into external neuromodulation surgery and internal neuromodulation surgery. External neuromodulation surgery is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Internal neuromodulation surgery is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others. By region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

By Surgery

Nerve Repair and Regeneration Market
By Surgery

Your browser does not support the canvas element.

Nueromodulation surgery segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

By surgery, the neuromodulation surgery segment was the highest contributor owing to an increase in a number of product approvals, and the rise in awareness of the benefits of using external neuromodulators is anticipated to boost the market growth. However, the direct nuropathy segment is expected to witness considerable growth during the forecast period.

By Product

Nerve Repair and Regeneration Market
By Product

Your browser does not support the canvas element.

nueromodulation surgery devices segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Depending on the product, the neuromodulation surgery devices segment was the highest contributor owing to the rise in consumer awareness among consumers about nerve repair and innovative technological advancements in the healthcare sector. However, the Biomaterials segment is expected to witness considerable growth during the forecast period.

By Region

Nerve Repair and Regeneration Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Region-wise, North America dominated the nerve repair and regeneration market share, in 2020, and is expected to be dominant during the forecast period, owing to a rise in the prevalence of neurodegenerative & neurodevelopmental diseases, stroke, and traumatic brain injuries; an increase in the adoption of advanced healthcare infrastructure; and rise in patient awareness about nerve repair and regeneration modalities.

However, Asia Pacific is expected to register the highest CAGR of 7.5 from 2021 to 2030, owing to an increase in the target population base, rising awareness among patients, supportive government initiatives, the presence of unmet medical needs, and the advent of innovative technologies are the major factor drives the growth of the nerve repair and regeneration industry.

The major companies profiled in this report include Abbott Laboratories, AxoGen Inc., Boston Scientific Incorporation, Integra Lifesciences Corporation, Medtronic plc, NeuroPace, Inc., NeuroSigma, Polyganics B.V., Stryker Corporation, Synovis Micro Companies Alliance, Inc


Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nerve repair and regeneration market analysis from 2020 to 2030 to identify the prevailing nerve repair and regeneration market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nerve repair and regeneration market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nerve repair and regeneration market trends, key players, market segments, application areas, and market growth strategies.

 

Key Market Segments

  • By Product
    • Biomaterials
    • Neuromodulation Surgery Devices
  • By Surgery
    • Stem Cell Therapy
    • Neuromodulation Surgery
    • Direct Neuropathy
    • Nerve Grafting
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest Of Asia Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest Fo Lamea


Key Market Players

  • Abbott Laboratories
  • Boston scientific inc
  • Integra Lifesciences Corporation
  • Medtronic plc
  • Axogenic
  • Stryker Corporation
  • Checkpoint Surgical
  • Polyganics
  • Synovis Micro Companies Alliance
  • OrthoMed, Inc
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Biomaterials

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Neuromodulation Surgery Devices

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

  • CHAPTER 5: NERVE REPAIR AND REGENERATION MARKET, BY SURGERY

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Direct Neuropathy

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Nerve Grafting

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Stem Cell Therapy

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

    • 5.5 Neuromodulation Surgery

      • 5.5.1 Key market trends, growth factors and opportunities

      • 5.5.2 Market size and forecast, by region

      • 5.5.3 Market analysis by country

  • CHAPTER 6: NERVE REPAIR AND REGENERATION MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Product

      • 6.2.3 North America Market size and forecast, by Surgery

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Product
          • 6.2.4.1.2 Market size and forecast, by Surgery
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Product
          • 6.2.4.2.2 Market size and forecast, by Surgery
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Product
          • 6.2.4.3.2 Market size and forecast, by Surgery
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Product

      • 6.3.3 Europe Market size and forecast, by Surgery

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Product
          • 6.3.4.1.2 Market size and forecast, by Surgery
        • 6.3.4.2 France
          • 6.3.4.2.1 Market size and forecast, by Product
          • 6.3.4.2.2 Market size and forecast, by Surgery
        • 6.3.4.3 U.K.
          • 6.3.4.3.1 Market size and forecast, by Product
          • 6.3.4.3.2 Market size and forecast, by Surgery
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Market size and forecast, by Product
          • 6.3.4.4.2 Market size and forecast, by Surgery
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Market size and forecast, by Product
          • 6.3.4.5.2 Market size and forecast, by Surgery
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Market size and forecast, by Product
          • 6.3.4.6.2 Market size and forecast, by Surgery
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Product

      • 6.4.3 Asia-Pacific Market size and forecast, by Surgery

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Market size and forecast, by Product
          • 6.4.4.1.2 Market size and forecast, by Surgery
        • 6.4.4.2 China
          • 6.4.4.2.1 Market size and forecast, by Product
          • 6.4.4.2.2 Market size and forecast, by Surgery
        • 6.4.4.3 Australia
          • 6.4.4.3.1 Market size and forecast, by Product
          • 6.4.4.3.2 Market size and forecast, by Surgery
        • 6.4.4.4 India
          • 6.4.4.4.1 Market size and forecast, by Product
          • 6.4.4.4.2 Market size and forecast, by Surgery
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Market size and forecast, by Product
          • 6.4.4.5.2 Market size and forecast, by Surgery
        • 6.4.4.6 Rest Of Asia Pacific
          • 6.4.4.6.1 Market size and forecast, by Product
          • 6.4.4.6.2 Market size and forecast, by Surgery
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Product

      • 6.5.3 LAMEA Market size and forecast, by Surgery

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Market size and forecast, by Product
          • 6.5.4.1.2 Market size and forecast, by Surgery
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Market size and forecast, by Product
          • 6.5.4.2.2 Market size and forecast, by Surgery
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Market size and forecast, by Product
          • 6.5.4.3.2 Market size and forecast, by Surgery
        • 6.5.4.4 Rest Fo Lamea
          • 6.5.4.4.1 Market size and forecast, by Product
          • 6.5.4.4.2 Market size and forecast, by Surgery
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Abbott Laboratories

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Boston scientific inc

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Integra Lifesciences Corporation

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Medtronic plc

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Axogenic

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Stryker Corporation

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Checkpoint Surgical

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Polyganics

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Synovis Micro Companies Alliance

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 OrthoMed, Inc

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

    Note: Details on financial performance and strategic moves and developments may not be captured for unlisted companies.

  • LIST OF TABLES

  • TABLE 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
    TABLE 2. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
    TABLE 3. NERVE REPAIR AND REGENERATION MARKET BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 4. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR NEUROMODULATION SURGERY DEVICES, BY REGION , 2020-2030,($MILLION)
    TABLE 5. NERVE REPAIR AND REGENERATION MARKET NEUROMODULATION SURGERY DEVICES BY COUNTRY, 2020-2030,($MILLION)
    TABLE 6. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
    TABLE 7. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR DIRECT NEUROPATHY, BY REGION , 2020-2030,($MILLION)
    TABLE 8. NERVE REPAIR AND REGENERATION MARKET DIRECT NEUROPATHY BY COUNTRY, 2020-2030,($MILLION)
    TABLE 9. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR NERVE GRAFTING, BY REGION , 2020-2030,($MILLION)
    TABLE 10. NERVE REPAIR AND REGENERATION MARKET NERVE GRAFTING BY COUNTRY, 2020-2030,($MILLION)
    TABLE 11. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR STEM CELL THERAPY, BY REGION , 2020-2030,($MILLION)
    TABLE 12. NERVE REPAIR AND REGENERATION MARKET STEM CELL THERAPY BY COUNTRY, 2020-2030,($MILLION)
    TABLE 13. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR NEUROMODULATION SURGERY, BY REGION , 2020-2030,($MILLION)
    TABLE 14. NERVE REPAIR AND REGENERATION MARKET NEUROMODULATION SURGERY BY COUNTRY, 2020-2030,($MILLION)
    TABLE 15. NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2020-2030,($MILLION)
    TABLE 16. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
    TABLE 17. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
    TABLE 18. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 19. U.S. NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 20. U.S. NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 21. CANADA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 22. CANADA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 23. MEXICO NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 24. MEXICO NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 25. EUROPE NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
    TABLE 26. EUROPE NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
    TABLE 27. EUROPE NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 28. GERMANY NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 29. GERMANY NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 30. FRANCE NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 31. FRANCE NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 32. U.K. NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 33. U.K. NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 34. ITALY NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 35. ITALY NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 36. SPAIN NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 37. SPAIN NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 38. REST OF EUROPE NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 39. REST OF EUROPE NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 40. ASIA-PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
    TABLE 41. ASIA-PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
    TABLE 42. ASIA-PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 43. JAPAN NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 44. JAPAN NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 45. CHINA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 46. CHINA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 47. AUSTRALIA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 48. AUSTRALIA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 49. INDIA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 50. INDIA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 51. SOUTH KOREA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 52. SOUTH KOREA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 53. REST OF ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 54. REST OF ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 55. LAMEA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
    TABLE 56. LAMEA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
    TABLE 57. LAMEA NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 58. BRAZIL NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 59. BRAZIL NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 60. SAUDI ARABIA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 61. SAUDI ARABIA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 62. SOUTH AFRICA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 63. SOUTH AFRICA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 64. REST FO LAMEA NERVE REPAIR AND REGENERATION MARKET BY PRODUCT 2020-2030,($MILLION)
    TABLE 65. REST FO LAMEA NERVE REPAIR AND REGENERATION MARKET BY SURGERY 2020-2030,($MILLION)
    TABLE 66.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 67.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 68.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 69.ABBOTT LABORATORIES: NET SALES,
    TABLE 70.ABBOTT LABORATORIES: KEY STRATEGIES
    TABLE 71.BOSTON SCIENTIFIC INC: COMPANY SNAPSHOT
    TABLE 72.BOSTON SCIENTIFIC INC: OPERATING SEGMENTS
    TABLE 73.BOSTON SCIENTIFIC INC: PRODUCT PORTFOLIO
    TABLE 74.BOSTON SCIENTIFIC INC: NET SALES,
    TABLE 75.BOSTON SCIENTIFIC INC: KEY STRATEGIES
    TABLE 76.INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
    TABLE 77.INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
    TABLE 78.INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
    TABLE 79.INTEGRA LIFESCIENCES CORPORATION: NET SALES,
    TABLE 80.INTEGRA LIFESCIENCES CORPORATION: KEY STRATERGIES
    TABLE 81.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 82.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 83.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 84.MEDTRONIC PLC: NET SALES,
    TABLE 85.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 86.AXOGENIC: COMPANY SNAPSHOT
    TABLE 87.AXOGENIC: OPERATING SEGMENTS
    TABLE 88.AXOGENIC: PRODUCT PORTFOLIO
    TABLE 89.AXOGENIC: NET SALES,
    TABLE 90.AXOGENIC: KEY STRATEGIES
    TABLE 91.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 92.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 93.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 94.STRYKER CORPORATION: NET SALES,
    TABLE 95.STRYKER CORPORATION: KEY STRATERGIES
    TABLE 96.CHECKPOINT SURGICAL: COMPANY SNAPSHOT
    TABLE 97.CHECKPOINT SURGICAL: OPERATING SEGMENTS
    TABLE 98.CHECKPOINT SURGICAL: PRODUCT PORTFOLIO
    TABLE 99.CHECKPOINT SURGICAL: NET SALES,
    TABLE 100.CHECKPOINT SURGICAL: KEY STRATEGIES
    TABLE 101.POLYGANICS: COMPANY SNAPSHOT
    TABLE 102.POLYGANICS: OPERATING SEGMENTS
    TABLE 103.POLYGANICS: PRODUCT PORTFOLIO
    TABLE 104.POLYGANICS: NET SALES,
    TABLE 105.POLYGANICS: KEY STRATEGIES
    TABLE 106.SYNOVIS MICRO COMPANIES ALLIANCE: COMPANY SNAPSHOT
    TABLE 107.SYNOVIS MICRO COMPANIES ALLIANCE: OPERATING SEGMENTS
    TABLE 108.SYNOVIS MICRO COMPANIES ALLIANCE: PRODUCT PORTFOLIO
    TABLE 109.SYNOVIS MICRO COMPANIES ALLIANCE: NET SALES,
    TABLE 110.SYNOVIS MICRO COMPANIES ALLIANCE: KEY STRATEGIES
    TABLE 111.ORTHOMED, INC: COMPANY SNAPSHOT
    TABLE 112.ORTHOMED, INC: OPERATING SEGMENTS
    TABLE 113.ORTHOMED, INC: PRODUCT PORTFOLIO
    TABLE 114.ORTHOMED, INC: NET SALES,
    TABLE 115.ORTHOMED, INC: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.NERVE REPAIR AND REGENERATION MARKET SEGMENTATION
    FIGURE 2.NERVE REPAIR AND REGENERATION MARKET,2020-2030
    FIGURE 3.NERVE REPAIR AND REGENERATION MARKET,2020-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.NERVE REPAIR AND REGENERATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.NERVE REPAIR AND REGENERATION MARKET,BY PRODUCT,2020(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BIOMATERIALS NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NEUROMODULATION SURGERY DEVICES NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
    FIGURE 15.NERVE REPAIR AND REGENERATION MARKET,BY SURGERY,2020(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIRECT NEUROPATHY NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF NERVE GRAFTING NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF STEM CELL THERAPY NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF NEUROMODULATION SURGERY NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
    FIGURE 20.NERVE REPAIR AND REGENERATION MARKET BY REGION,2020
    FIGURE 21.U.S. NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 22.CANADA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 23.MEXICO NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 24.GERMANY NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 25.FRANCE NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 26.U.K. NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 27.ITALY NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 28.SPAIN NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 29.REST OF EUROPE NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 30.JAPAN NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 31.CHINA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 32.AUSTRALIA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 33.INDIA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 34.SOUTH KOREA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 35.REST OF ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 36.BRAZIL NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 37.SAUDI ARABIA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 38.SOUTH AFRICA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 39.REST FO LAMEA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
    FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 44.COMPETITIVE DASHBOARD
    FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 46.ABBOTT LABORATORIES.: NET SALES,($MILLION)
    FIGURE 47.BOSTON SCIENTIFIC INC.: NET SALES,($MILLION)
    FIGURE 48.INTEGRA LIFESCIENCES CORPORATION.: NET SALES,($MILLION)
    FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 50.AXOGENIC.: NET SALES ,($MILLION)
    FIGURE 51.STRYKER CORPORATION.: NET SALES,($MILLION)
    FIGURE 52.CHECKPOINT SURGICAL.: NET SALES,($MILLION)
    FIGURE 53.POLYGANICS.: NET SALES,($MILLION)
    FIGURE 54.SYNOVIS MICRO COMPANIES ALLIANCE.: NET SALES,($MILLION)
    FIGURE 55.ORTHOMED, INC.: NET SALES,($MILLION)

 
 

This section provides opinions of the top-level CXOs operating in the global nerve repair and regeneration market. According to the insights of the CXOs, the global nerve repair and regeneration market is expected to exhibit high growth potential attributable to factors such as a rise in R&D activities in the pharmaceutical industry for manufacturing of nerve repair ®eneration devices, an increase in the prevalence of the neurological disorder, and surge in a number of approvals by the U.S. Food and Drug Administration (FDA) for neuromodulator. The market has gained traction among healthcare providers owing to several benefits offered by these devices to treat neurological disorders and improve the quality of life of the patients. There have been significant technological advancements in these devices to provide advanced treatment options to manage symptoms of neurological disorders. As the market is nascent and growing at a steady rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Nerve Repair and RegenerationMarket is $12.3 billion in 2020

A. The market value of the Nerve Repair and Regeneration Market in 2020 s $6.6 billion?

A. The major factors that enhance the market growth are an increase in the geriatric population, the rise in the incidence of neurological & epidemic disorders, and the launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth

A. North America is the largest regional market for Nerve Repair and Regeneration

A. Abbott Laboratories, AxoGen Inc., Boston Scientific Incorporation, Integra Lifesciences Corporation, Medtronic plc are the top companies to hold the market share in Nerve Repair and Regeneration

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Nerve Repair And Regeneration Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,565
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,961
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,939
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,654
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,280
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers